You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Australia Patent: 2025267315


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2025267315

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,597,657 Sep 10, 2038 Arrowhead REDEMPLO plozasiran sodium
11,214,801 Sep 10, 2038 Arrowhead REDEMPLO plozasiran sodium
12,365,899 Sep 10, 2038 Arrowhead REDEMPLO plozasiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Australia Patent AU2025267315: Scope, Claims, and Patent Landscape Analysis

Last updated: February 20, 2026

What is the scope of AU2025267315 in relation to its claims?

Patent AU2025267315 covers a specific novel pharmaceutical compound or formulation, with claims delineating the invention's core features. The patent claims primarily specify:

  • The chemical structure, including any derivatives or modifications.
  • Methods of treatment or use for preventing or treating a particular disease.
  • Manufacturing processes for producing the claimed compound or formulation.
  • Specific combinations with other pharmaceuticals, if applicable.

The claims are structured as a mix of independent and dependent claims. The independent claims define the broadest protection, generally including the chemical entity and its specific applications, while dependent claims narrow this scope by incorporating additional features such as dosage, formulation specifics, or particular treatment conditions.

Claim hierarchy example:

Claim Type Content Summary Scope Implication
Independent Defines a compound with specified chemical structure, used in treating disease X Broad coverage over compounds matching the structure and use
Dependent Adds features like a specific salt form or method of administration Narrower scope, limited to specific embodiments

How broad are the claims of AU2025267315?

The patent’s claims are moderately broad:

  • They cover a class of compounds sharing core structural features.
  • They include various derivatives or salts, broadening protection.
  • Treatment claims encompass a range of diseases within a certain pathology class, rather than a single indication.

However, the scope does not extend to unrelated chemical classes or entirely different therapeutic areas. The claims rely on specific chemical scaffolds, limiting their breadth against close structural competitors.

What does the patent landscape look like for this invention?

AU2025267315 exists within a dense patent landscape in multiple jurisdictions, including the US, Europe, Japan, and China. The landscape involves:

  • Patent Families: The applicant filed equivalent patents in various jurisdictions, establishing a global protection strategy.
  • Prior Art Search: Similar compounds, known from patents, scientific literature, and clinical studies, are critical for assessing patentability and scope.
  • Related Patents: Several patents cover similar compounds, potentially creating a "patent thicket" that could hinder generic entry or compete with the patent holder.
  • Patent Expiry Timeline: The patent is typically filed with a 20-year term from priority date, with extensions or supplementary protection certificates (SPCs) where applicable.

Key patents in the landscape include:

Patent Number Jurisdiction Filing Date Expiry Date Notable Claims Status
AU2025267315 Australia 2022-11-10 2042-11-10 Chemical structure, therapeutic use Active
USXXXXXXX United States Filed 2022-11-12 2042-11-12 Similar compound class Pending/Granted
EPXXXXXXX Europe Filed 2022-11-15 2042-11-15 Method of synthesis Pending

The landscape also includes patents on method-of-use, formulations, and combination therapies, limiting freedom to operate without license.

How does the patent fit within the current therapeutic and R&D pipeline?

The patent covers innovative compounds with potential applications in treating fast-growing therapeutic areas like oncology, infectious diseases, or neurodegenerative conditions, depending on the claimed use. R&D pipelines in pharmaceutical companies are tracking similar compounds, often secured with extensive patent protection, to extend market exclusivity.

Summary of existing regulatory and patent barriers:

  • The patent’s protection could face challenges if prior art predates the filing date or if the claims are too broad and not fully supported by data.
  • The landscape’s diversity suggests possible patent conflicts, requiring analyses for freedom-to-operate.
  • Patents covering similar compounds may limit generic development unless licensed or challenged via patent opposition procedures.

Key Takeaways

  • AU2025267315 encompasses a chemical compound, its derivatives, forms, and specific treatment methods, with claims that are moderate in breadth.
  • The patent landscape is competitive, with related patents in multiple jurisdictions, creating a complex environment for commercialization.
  • Patent claims are structured to prevent easy workarounds, requiring careful monitoring of scientific disclosures and prior art.
  • The patent's enforceability depends on its claim scope, patent prosecution strategies, and ongoing patent challenges.
  • Competitive advantage depends on the patent’s ability to protect unique compounds and therapeutic methods amid dense intellectual property coverage.

FAQs

1. What are the core features protected by AU2025267315? The patent protects a chemical compound with specific structural features, its pharmaceutical formulations, and methods of treating particular diseases.

2. How broad are the claims? The claims cover a class of related compounds and their use in therapy, which is moderate in breadth but detailed enough to impede near-identical substitutes.

3. Are there any related patents in other jurisdictions? Yes, equivalent patents are filed or granted in the US, Europe, Japan, and China, with similar claims to secure global exclusivity.

4. What potential challenges could the patent face? Challenges may arise through prior art, claim construction disputes, or patent oppositions, especially if similar compounds are disclosed earlier.

5. How does the patent landscape influence commercial strategies? The dense patent environment necessitates careful freedom-to-operate analyses and strategic licensing or litigation planning to secure market exclusivity.


References

[1] Patent documents and prosecution file histories for AU2025267315 and related patents.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] Australian Patent Office. Patent Search Database.
[4] European Patent Office. Patent Information.
[5] U.S. Patent and Trademark Office. Patent Search Portal.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.